Public Procurement for Biological Medicines in Belgium: The Royal Decree of 13 September 2023 opens the door for compulsory tendering when biosimilars enter the market. Can virtue afford to flirt with legality?
The Royal Decree of September 13, 2023 (‘RD’), implementing Article 71bis, § 1, of the Belgian Act on Compulsory Health Care Insurance and Benefits (‘Wet betreffende de verplichte verzekering voor geneeskundige verzorging en uitkeringen’), which establishes specific regulations for public procurement concerning biological medicines, was published in the Belgian Official Gazette on September 22, 2023.
The impact of this Royal Decree on the sector could be significant,...
September 27, 2023
7 min read